In this issue, Takahara and Maeda (2012) discover that together, Pbp1 and sequestration of the TORC1 complex in cytoplasmic mRNP stress granules provides a negative regulatory mechanism for TORC1 signaling during stress.
The TOR kinase, as part of TOR complex 1 (TORC1), is a central regulator of cell growth in eukaryotes with effects on cancer development, aging, and metabolism. In optimal conditions, TORC1 drives mass accumulation by promoting protein synthesis while repressing catabolic pathways such as autophagy ( Figure 1A ). However, in the absence of growth hormones, or during stress or starvation, TORC1 is inactivated, limiting growth. A key issue is how TORC1 is regulated. Several pathways stimulate TORC1 in response to growth factors, including the PI3 kinases, AKT, ERK, and the tuberous sclerosis proteins TSC1/TSC2, which are all regulators of tumor progression. Insight has also recently emerged into how TORC1 is controlled by stress and nutrients. For example, TORC1 is activated by small GTPases, called Rags, in part through recruitment to the vacuolar membrane ( Figure 1A) . Strikingly, the Rag GTPases are only activated when leucine levels are high as sensed by the leucyl transfer RNA synthase (Bonfils et al., 2012) . In contrast, during stress or nitrogen starvation, another small GTPase located on the vacuolar membrane, Rho1, transiently binds to TORC1, releasing it from the membrane and triggering its inactivation (Yan et al., 2012) (Figure 1B ). In this issue of Molecular Cell, work from Takahara and Maeda (2012) now suggest that TORC1 is also repressed during stress by sequestration into cytoplasmic messenger ribonucleoprotein (mRNP) aggregates known as stress granules ( Figure 1B) .
The authors first identify a link between stress granule formation and TOR when they find that in Saccharomyces cerevisiae, overexpression of Pbp1 suppresses growth defects caused by a hyperactive TOR allele and reduces the recovery of TOR activity during alleviation of nitrogen or glucose starvation. Pbp1 and its human ortholog Ataxin-2 both promote stress granule formation and have roles in regulating messenger RNA (mRNA) function (Nonhoff et al., 2007; Buchan et al., 2008) . Stress granules are conserved cytoplasmic aggregates of nontranslating mRNPs in association with some translation initiation factors and mRNA binding proteins (Buchan and Parker, 2009) . Stress granules are typically observed under conditions, such as stress, in which translation initiation is limited and nontranslating mRNPs accumulate and aggregate. The function of mRNP aggregation into stress granules is not fully understood, but it is suggested to regulate mRNA translation and degradation, as well as to affect signaling pathways. Such functions are consistent with stress granule formation correlating with better survival during stress (Kwon et al., 2007; Eisinger-Mathason et al., 2008) .
Takahara and Maeda's main argument, that sequestration of TORC1 in stress granules is inhibitory for TORC1 function, is supported as follows: First, the authors show that Kog1 (a TORC1 subunit) and Tor1 can localize in stress granules and coimmunoprecipitate with Pbp1. Second, they demonstrate that the ability of Pbp1 to downregulate TOR signaling, coimmunoprecipitate with TORC1, and recruit TORC1 into stress granules depends on Pbp1's ability to self-associate, which is also necessary for Pbp1 to both localize within and promote assembly of stress granules. Third, kinetic analysis showed that recovery of TOR signaling after stress correlates with its exit from stress granules, while genetic and chemical approaches that alter stress granule formation also correlated positively with TOR signaling activity. The authors' model argues that stress first inactivates TOR (likely through Rho1) and inhibits translation, which promotes stress granule formation and sequestration of some TORC1 molecules. The sequestered TORC1 is then reduced in function until the stress is alleviated. As stress granules disassemble, the amount of active TORC1 would increase. Such a mechanism might provide a control circuit wherein TOR signaling, which stimulates the production of the translation machinery, is limited until the cell has recovered from the stress response and reactivated the translation machinery. Moreover, since stress or nutrient deprivations can be transient, recruitment and eventual release of TORC1 from stress granules could allow differential control over TORC1 inactivation in different conditions. Interestingly, TORC1 signaling also promotes translation initiation, in part by phosphorylation and inactivation of the 4E-BPs, which otherwise bind and inhibit the translation initiation factor eIF4E (Wullschleger et al., 2006) . Thus, when environmental conditions repress TORC1 signaling, the resulting inhibition of translation initiation promotes stress granule formation, which in turn recruits and further inhibits TORC1 signaling. This likely sets up a positive feedback loop to ensure that cells fully commit to a stress response if, and only when, stress levels are significant.
The work of Takahara and Maeda highlights the emerging role of stress granules in sequestering cell signaling molecules and thereby modulating cellular responses. For example, localization of the RACK1 kinase in mammalian stress granules during various stress conditions prevents RACK1 association with, and activation of, the kinase MTK1, thereby modulating apoptosis (Arimoto et al., 2008) . A similar phenomenon has also been observed with TRAF2 sequestration into heat shock-induced mammalian stress granules via interaction with eIF4G (Kim et al., 2005) . Thus, these examples argue that stress granules play a role as sites that help coordinate the regulation of the wide array of signaling pathways involved in the global stress response.
The work of Takahara and Maeda also has important implications for medicine. Formation of stress granule-like structures is observed in various disease states such as cancer, neurological disorders, and inflammatory disease (Buchan and Parker, 2009 ). Sequestration of TOR or other signaling factors in stress granules could be part of these etiologies. Additionally, disease states characterized by cellular stresses such as nutrient Figure 1 . Regulation of TORC1 Signaling (A) Under optimal conditions, the PI3K/AKT and ERK hormone response pathways cooperate with the Rag GTPases to activate TORC1 at the vacuolar membrane. Activated TORC1 then drives growth by promoting protein synthesis and repressing catabolic processes such as autophagy. (B) During starvation and/or stress, another GTPase, Rho1, inactivates TORC1 and triggers its release from the vacuole. TORC1 inhibition is then maintained by sequestration into stress granules. The mRNP regulatory protein Pbp1 in particular negatively regulates TORC1 signaling, in a manner dependent on its ability to localize within and promote stress granule aggregation.
deprivation (e.g., diabetes) might also involve a role for TOR sequestration in stress granules. Understanding the interplay of TOR activity with stress granule function may lead to better insight into the underlying causes of such disease and allow identification of more-specific drug targets, given the relatively blunt nature of current TOR-targeted therapies such as Rapamycin. Moreover, it will be important to understand how all these different TORC1 regulatory systems are integrated to appropriately regulate cell growth and catabolism under a wide variety of cell states.
